DOJ, SEC issue subpoena to Johnson & Johnson over baby product safety
By Nikita Chaurasia  Date: 2019-02-26

DOJ, SEC issue subpoena to Johnson & Johnson over baby product safety

Johnson & Johnson is presently facing lawsuits involving 13,000 plaintiffs.

Pharmaceutical and consumer products giant Johnson & Johnson has confirmed that it has received subpoenas from the U.S. Department of Justice as well as the Securities and Exchange Commission (SEC), with regard to investigations into alleged asbestos contamination in the products from its well-known Baby Powder line.

Apparently, the company aims to fully cooperate with inquiries from the authorities and would keep defending itself against talc product-related litigation. In its annual report issued recently, the company accepted for the first time that it had received subpoenas from U.S. agencies over safety concerns regarding its talc power products, Reuters has mentioned. 

The DOJ and SEC did not seem to have offered any comments for responding to the news. 

A report released in December said that Johnson & Johnson was aware for decades that asbestos, which is a recognized carcinogen, had been found several times in its talc and powder products in small amounts. The company had allegedly failed to disclose this information, found out from tests conducted from 1970s to early 2000s, to the public and the regulators.

Records show that the information revealed had led to Johnson & Johnson shares losing about $40 billion from the market valuation in a single day. It had also triggered a public relations disaster involving worldwide inquiries about probable health effects of its signature product.

For its part, the company has stated that inquiries from federal agencies are based on news reports which consisted of inaccurate statements, besides withholding vital information that were made public already. Johnson & Johnson has insisted that for decades, independent testing performed by regulators and leading laboratories around the world have proven its baby power is asbestos-free, safe to use and does not cause cancer.

For the record, Johnson & Johnson is facing lawsuits involving 13,000 plaintiffs who claim using the company’s talc products, such as Baby Powder, have caused cancer.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

ClaimBuddy secures undisclosed sum in Titan Capital-led funding round
ClaimBuddy secures undisclosed sum in Titan Capital-led funding round
By Nikita Chaurasia

Indian insurance technology startup ClaimBuddy has reportedly raised an undisclosed amount in a seed funding round which was led by Titan Capital and involved participation from other marquee investor groups including First Cheque as well as LV Angel...

Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
By Nikita Chaurasia

Daimler AG owned German automotive giant, Mercedes-Benz, has reportedly introduced the EQA, a new electric compact SUV to compete with market leader Tesla, Inc. as well as to meet its carbon targets in China and Europe. The Mercedes-Benz EQA, one of...

New York planning on direct purchase of Pfizer’s COVID-19 vaccines
New York planning on direct purchase of Pfizer’s COVID-19 vaccines
By Nikita Chaurasia

In recent developments, Governor of New York, Andrew Cuomo has reportedly issued a letter to the CEO of American drug maker Pfizer Inc., Albert Bourla, requesting for direct purchase of COVID-19 vaccine doses. Although the company is not bound to any...

Mayo Clinic Laboratories forms alliance with American Hospital Dubai
Mayo Clinic Laboratories forms alliance with American Hospital Dubai
By Nikita Chaurasia

In recent developments, Minnesota-based Mayo Clinic Laboratories and American Hospital Dubai are reportedly planning on entering a strategic alliance which is aimed at enhancing advanced laboratory diagnostic services in Dubai. Under the terms of th...

LTI, IBM extend global partnership to spearhead digital transformation
LTI, IBM extend global partnership to spearhead digital transformation
By Nikita Chaurasia

The New York-headquartered IBM Corp., with its global partner Larsen Toubro Infotech, an Indian global IT solutions & services company, are planning to extend their multi-year partnership, in a bid to enable companies to revolutionize the busines...